Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Greater Fool who wrote (91895)	1/23/2000 12:45:00 AM
From: Mark Fowler	Read Replies (1) \| Respond to of 164684

The runup in the genome stocks is about as insane as the runup in some of the more ephemeral web stocks. Affymetrix, for example, is a rinky-dink company, with one manufacturing facility in Sacramento. If the worldwide market for the product was as large as the stock market seems to think it is, wouldn't they be building lots and lots of great big manufacturing facilities?!?<< They also have a rinky-dink facility in Santa Clara Valley... affymetrix.com "Being the dominant genomics tools company, Affymetrix should benefit significantly from the genomics stock rally," To said. He said he expects the company to turn profitable by the end of this year, and that its competitive edge is sharpened by a strong patent position. He raised his target to $250 a share from $150. Shares of Affymetrix jumped 30 1/4 to 232 1/2. " cbs.marketwatch.com